Ligand Pharmaceuticals Inc (NASDAQ:LGND)

Delayed Data
As of May 06
 +0.78 / +1.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 92.00, with a high estimate of 116.00 and a low estimate of 82.00. The median estimate represents a +17.27% increase from the last price of 78.45.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -55.00%
Growthannually 38.82%


Growthquarterly -41.13%
Growthannually 27.50%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account